Name
CVI
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for CVI
Name
Alternate Names
D 7093
Mesna rescue
Mesnex
Mesnex uroprotection
Mesnum
Mistabron
Mitexan
Mucofluid
Sodium 2-mercaptoethanolsulfonate
UCB 3983
Uromitexan
Abbreviations
None
Category
Ancillary Agent
Subcategory
None
NSC Number
113891
Primary Site
None
Histology
None
Remarks
A prophylactic detoxifying agent used to inhibit hemorrhagic cystitis caused by ifosfamide. FDA approved for bladder protection when using cyclophosphamide (prevents bladder toxicity).
Coding
This drug should NOT be coded
Name
Alternate Names
A-4942
Asta Z-4942
Cyfos#
Holoxan 1000
Ifex
Ifosfamid
Ifoxan
Iphosphamid
Iphosphamide
Iso-endoxan
Isofosfamide
Isophos-phamide
Isophosphamide
Mitoxana
MJF 9325
MJF-9325
Naxamide#
Z4942
Abbreviations
IFX
IPP
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
109724
Primary Site
Bladder
Cervical cancer
Ewing sarcoma
Head and Neck
Hodgkin lymphoma
Non-Hodgkin lymphoma
Soft tissue sarcoma, osteogenic sarcoma
Testicular cancer
Histology
None
Remarks
Antineoplastic with alkylating activity. FDA approved.
Coding
This drug should be coded
Name
Alternate Names
JM 8
JM-8
JM8
Paraplatin
Abbreviations
CBDCA
Category
Chemotherapy
Subcategory
Alkylating agent
Platinum analog
NSC Number
241240
Primary Site
All cancers
Histology
None
Remarks
A platinum-salt alkylating agent.
Coding
This drug should be coded